- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Mid-Large Cap Stocks
U.S. Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
156
Mid-Large Cap Stocks
156 companies
Zai Lab
Market Cap: US$3.1b
A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
ZLAB
US$28.75
7D
-1.3%
1Y
44.3%
10x Genomics
Market Cap: US$1.1b
A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.
TXG
US$9.20
7D
6.6%
1Y
-64.0%
Sotera Health
Market Cap: US$3.6b
Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$12.74
7D
-3.7%
1Y
11.7%
Charles River Laboratories International
Market Cap: US$6.8b
Charles River Laboratories International, Inc.
CRL
US$138.89
7D
-1.7%
1Y
-38.2%
Ocular Therapeutix
Market Cap: US$1.1b
A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.
OCUL
US$7.17
7D
-3.8%
1Y
14.4%
Ultragenyx Pharmaceutical
Market Cap: US$3.3b
A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.
RARE
US$34.84
7D
-3.2%
1Y
-18.2%
Legend Biotech
Market Cap: US$5.1b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$27.69
7D
-12.9%
1Y
-38.7%
Scholar Rock Holding
Market Cap: US$2.9b
A biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.
SRRK
US$30.83
7D
0.5%
1Y
146.8%
Verona Pharma
Market Cap: US$6.1b
A biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs.
VRNA
US$69.53
7D
4.9%
1Y
420.4%
CRISPR Therapeutics
Market Cap: US$3.1b
A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.
CRSP
US$36.31
7D
0.5%
1Y
-34.8%
Recursion Pharmaceuticals
Market Cap: US$1.8b
Operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States.
RXRX
US$4.25
7D
-3.2%
1Y
-55.3%
Moderna
Market Cap: US$9.3b
A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.
MRNA
US$23.65
7D
-3.0%
1Y
-82.2%